Preclinical Imaging (In-VIVO) Market by Modality (Optical Imaging, Nuclear Imaging, PET, SPECT, CT, MRI, Micro-Ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging) by Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes, Nuclear Imaging Reagents) and Region, Global Trends and Forecast from 2023 to 2030.

1. INTRODUCTION
   1. MARKET DEFINITION
   2. MARKET SEGMENTATION
   3. RESEARCH TIMELINES
   4. ASSUMPTIONS AND LIMITATIONS
2. RESEARCH METHODOLOGY
   1. DATA MINING
      1. SECONDARY RESEARCH
      2. PRIMARY RESEARCH
      3. SUBJECT-MATTER EXPERTS’ ADVICE
   2. QUALITY CHECKS
      1. FINAL REVIEW
   3. DATA TRIANGULATION
      1. BOTTOM-UP APPROACH
      2. TOP-DOWN APPROACH
      3. RESEARCH FLOW
   4. DATA SOURCES
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
   1. GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET OUTLOOK
      1. MARKET DRIVERS
      2. MARKET RESTRAINTS
      3. MARKET OPPORTUNITIES
   2. IMPACT OF COVID-19 ON PRECLINICAL IMAGING (IN-VIVO) MARKET
   3. PORTER’S FIVE FORCES MODEL
      1. THREAT FROM NEW ENTRANTS
      2. THREAT FROM SUBSTITUTES
      3. BARGAINING POWER OF SUPPLIERS
      4. BARGAINING POWER OF CUSTOMERS
      5. DEGREE OF COMPETITION
   4. INDUSTRY VALUE CHAIN ANALYSIS
5. GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY, 2020-2030, (USD MILLION).
   1. OPTICAL IMAGING
   2. NUCLEAR IMAGING
   3. PET
   4. SPECT
   5. CT
   6. MRI
   7. MICRO-ULTRASOUND
   8. PHOTOACOUSTIC IMAGING
   9. MAGNETIC PARTICLE IMAGING
6. GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT, 2020-2030, (USD MILLION).
   1. OPTICAL IMAGING REAGENTS
   2. CONTRAST AGENTS
   3. PET TRACERS
   4. SPECT PROBES
   5. NUCLEAR IMAGING REAGENTS
7. GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REGION, 2020-2030, (USD MILLION).
   1. NORTH AMERICA
      1. US
      2. CANADA
      3. MEXICO
   2. SOUTH AMERICA
      1. BRAZIL
      2. ARGENTINA
      3. COLOMBIA
      4. REST OF SOUTH AMERICA
   3. EUROPE
      1. GERMANY
      2. UK
      3. FRANCE
      4. ITALY
      5. SPAIN
      6. RUSSIA
      7. REST OF EUROPE
   4. ASIA PACIFIC
      1. INDIA
      2. CHINA
      3. JAPAN
      4. SOUTH KOREA
      5. AUSTRALIA
      6. SOUTH-EAST ASIA
      7. REST OF ASIA PACIFIC
   5. MIDDLE EAST AND AFRICA
      1. UAE
      2. SAUDI ARABIA
      3. SOUTH AFRICA
      4. REST OF MIDDLE EAST AND AFRICA

8. COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

1. PERKINELMER INC.
2. BRUKER CORPORATION
3. FUJIFILM HOLDINGS CORPORATION
4. MEDISO LTD.
5. MILABS B.V.
6. MR SOLUTIONS
7. LI-COR BIOSCIENCES
8. ASPECT IMAGING
9. TRIFOIL IMAGING
10. MILTENYI BIOTECH GMBH *THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1        GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLION), 2020-2030

TABLE 2        GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 3        GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REGION (USD MILLIONS), 2020-2030

TABLE 4        NORTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 5        NORTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 6        NORTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY COUNTRY (USD MILLION), 2020-2030

TABLE 7        US PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 8        US PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 9        CANADA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (MILLIONS), 2020-2030

TABLE 10      CANADA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 11      MEXICO PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 12      MEXICO PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 13      SOUTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 14      SOUTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 15      SOUTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY COUNTRY (USD MILLION), 2020-2030

TABLE 16      BRAZIL PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 17      BRAZIL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 18      ARGENTINA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 19      ARGENTINA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 20      REST OF SOUTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 21      REST OF SOUTH AMERICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 22      ASIA -PACIFIC PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 23      ASIA -PACIFIC PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 24      ASIA -PACIFIC PRECLINICAL IMAGING (IN-VIVO) MARKET BY COUNTRY (USD MILLION), 2020-2030

TABLE 25      INDIA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 26      INDIA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 27      CHINA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 28      CHINA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 29      JAPAN PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 30      JAPAN PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 31      SOUTH KOREA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 32      SOUTH KOREA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 33      AUSTRALIA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 34      AUSTRALIA HYBRID FUNCTIONBY REAGENT (USD MILLION), 2020-2030

TABLE 35      AUSTRALIA PRECLINICAL IMAGING (IN-VIVO) MARKET BY FUNCTION (USD MILLIONS), 2020-2030

TABLE 36      AUSTRALIA PRECLINICAL IMAGING (IN-VIVO) MARKET BY ORGANIZATION SIZE (USD MILLION), 2020-2030

TABLE 37      REST OF ASIA PACIFIC PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 38      REST OF ASIA PACIFIC HYBRID FUNCTIONBY REAGENT (USD MILLION), 2020-2030

TABLE 39      EUROPE PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 40      EUROPE PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 41      EUROPE PRECLINICAL IMAGING (IN-VIVO) MARKET BY COUNTRY (USD MILLION), 2020-2030

TABLE 42      GERMANY PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 43      GERMANY PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 44      UK PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 45      UK PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 46      FRANCE PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 47      FRANCE PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 48      ITALY PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 49      ITALY PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 50      SPAIN PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 51      SPAIN PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 52      REST OF EUROPE PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 53      REST OF EUROPE PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 54      MIDDLE EAST AND AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 55      MIDDLE EAST AND AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 56      MIDDLE EAST ABD AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY COUNTRY (USD MILLION), 2020-2030

TABLE 57      UAE PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 58      UAE PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 59      SOUTH AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 60      SOUTH AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

TABLE 61      REST OF MIDDLE EAST AND AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY (USD MILLIONS), 2020-2030

TABLE 62      REST OF MIDDLE EAST AND AFRICA PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT (USD MILLION), 2020-2030

LIST OF FIGURES             

FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8              GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY, USD MILLION, 2020-2030

FIGURE 9              GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT, USD MILLION, 2020-2030

FIGURE 10           GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REGION, USD MILLION, 2020-2030

FIGURE 11           PORTER’S FIVE FORCES MODEL

FIGURE 12           GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY MODALITY, USD MILLION, 2022

FIGURE 13           GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REAGENT, USD MILLION, 2022

FIGURE 14           GLOBAL PRECLINICAL IMAGING (IN-VIVO) MARKET BY REGION, USD MILLION, 2022

FIGURE 15           MARKET SHARE ANALYSIS

FIGURE 16           PERKINELMER INC.: COMPANY SNAPSHOT

FIGURE 17           BRUKER CORPORATION: COMPANY SNAPSHOT

FIGURE 18           FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT

FIGURE 19           MEDISO LTD.: COMPANY SNAPSHOT

FIGURE 20           MILABS B.V.: COMPANY SNAPSHOT

FIGURE 21           MR SOLUTIONS: COMPANY SNAPSHOT

FIGURE 22           LI-COR BIOSCIENCES: COMPANY SNAPSHOT

FIGURE 23           ASPECT IMAGING: COMPANY SNAPSHOT

FIGURE 24           TRIFOIL IMAGING: COMPANY SNAPSHOT

FIGURE 25           MILTENYI BIOTECH GMBH: COMPANY SNAPSHOT